Caliph Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Risalpur · Pakistan
Risalpur-based pharmaceutical manufacturer producing tablets, capsules, liquids, powders and topical formulations.
Caliph Pharmaceuticals products in Pakistan
Caliph Pharmaceuticals (Pvt) Ltd has 116 medicine presentations registered in Pakistan under 51 brands, covering 44 generic medicines. Most of its products are in Anti-infectives, Dermatology and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Calphacin (Clarithromycin), Calsic (Omeprazole), Riscalm (Risperidone) and Betacline-G (Betamethasone + Gentamicin). 116 products have an official DRAP price on MedInfoBase. See all 51 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Caliph Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 17, Special Industrial Zone (EPZ), Risalpur, Khyber Pakhtunkhwa, Pakistan
- Website
- caliphpharma.com.pk ↗
- Phone
- +92 339 4091138
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Caliph Pharmaceuticals (Pvt) Ltd. is priced against the market
93 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| A-zatro | Azithromycin | 200 mg/5 mL | Dry suspension | 15ml | 080405 | PKR 290.35 | PKR 19.36/mL | 🔒 Pharma Pro |
| Betacline | Betamethasone | 0.05 % | Lotion | 60ml | 104163 | PKR 131.98 | PKR 2.20/mL | No comparator |
| Betacline | Betamethasone | 0.05 % | Lotion | 20ml | 104163 | PKR 52.79 | PKR 2.64/mL | No comparator |
| Betacline | Betamethasone | 0.05% | Ointment | 15gm | 107836 | PKR 52.79 | PKR 3.52/g | 🔒 Pharma Pro |
| Betacline V | Betamethasone valerate | 0.1% | Lotion | 30ml | 104162 | PKR 105.58 | PKR 3.52/mL | 🔒 Pharma Pro |
| Betacline V | Betamethasone | 0.1 % | Lotion | 20ml | 104162 | PKR 70.39 | PKR 3.52/mL | 🔒 Pharma Pro |
| Betacline-G | Betamethasone + Gentamicin | 0.5 mg + 1 mg | Cream | 15gm | 096918 | PKR 112.61 | PKR 7.51/g | 🔒 Pharma Pro |
| Betacline-G | Betamethasone + Gentamicin | 0.5 mg/g + 1 mg/g | Cream | 30gms | 096918 | PKR 220.09 | PKR 7.34/g | No comparator |
| Betacline-G | Betamethasone + Gentamicin | 0.5 mg + 1 mg | Ointment | 15gm | 096919 | PKR 114.31 | PKR 7.62/g | No comparator |
| Betacline-G | Betamethasone + Gentamicin | 0.5 mg/g + 1 mg/g | Ointment | 30gms | 096919 | PKR 223.50 | PKR 7.45/g | No comparator |
| Betacline-S | Betamethasone + Salicylic acid | 0.5 mg + 30 mg | Ointment | 15gm | 096920 | PKR 85.30 | PKR 5.69/g | 🔒 Pharma Pro |
| Betacline-S | Betamethasone + Salicylic acid | 0.5 mg/g + 30 mg/g | Ointment | 30gms | 096920 | PKR 167.20 | PKR 5.57/g | No comparator |
| Betacline-S | Betamethasone + Salicylic acid | 0.5 mg + 20 mg | Lotion | 20ml | 096921 | PKR 112.61 | PKR 5.63/mL | No comparator |
| Betacline-S | Betamethasone + Salicylic acid | 0.05% + 2% | Lotion | 60ml | 096921 | PKR 324.16 | PKR 5.40/mL | No comparator |
| Bicalutacal | Bicalutamide | 50 mg | Tablet | 28's | 100255 | PKR 5,444.38 | PKR 194.44/tablet | 🔒 Pharma Pro |
| Bicalutacal | Bicalutamide | 150 mg | Tablet | 28's | 100256 | PKR 12,711.77 | PKR 453.99/tablet | No comparator |
| Bicalutacal | Bicalutamide | 150 mg | Tablet | 1's | 100256 | PKR 453.99 | PKR 453.99/tablet | No comparator |
| Caladar | Sulfadoxine + Pyrimethamine | 500 mg + 25 mg | Suspension | 15ml | 080247 | PKR 25.59 | PKR 1.71/mL | No comparator |
| Caladar | Sulfadoxine + Pyrimethamine | 500 mg + 25 mg | Suspension | 30ml | 080247 | PKR 73.36 | PKR 2.45/mL | No comparator |
| Calazi | Azithromycin | 250 mg | Capsule | 6's | 073399 | PKR 269.22 | PKR 44.87/capsule | 🔒 Pharma Pro |
| Calazi | Azithromycin | 250 mg | Capsule | 10's | 073399 | PKR 448.71 | PKR 44.87/capsule | 🔒 Pharma Pro |
| Calazi | Azithromycin | 500 mg | Tablet | 6's | 104160 | PKR 483.91 | PKR 80.65/tablet | 🔒 Pharma Pro |
| Calazi | Azithromycin | 1 g | Sachet | 1's | 104161 | PKR 158.37 | PKR 158.37/sachet | 🔒 Pharma Pro |
| Califer | Iron | 50 mg/5 mL | Syrup | 60ml | 080403 | PKR 123.17 | PKR 2.05/mL | 🔒 Pharma Pro |
| Califer | Iron | 50 mg | Syrup | 120ml | 080403 | PKR 234.04 | PKR 1.95/mL | No comparator |
| Califer | Iron polymaltose complex | 100 mg elemental iron | Tablet | 10's | 095218 | PKR 119.42 | PKR 11.94/tablet | 🔒 Pharma Pro |
| Califer-F | Iron polymaltose complex + Folic acid | 50 mg + 0.35 mg/5 mL | Syrup | 60ml | 085520 | PKR 119.42 | PKR 1.99/mL | 🔒 Pharma Pro |
| Califer-F | Elemental iron + Folic acid | 50 mg + 0.35 mg/5 mL | Syrup | 120ml | 085520 | PKR 233.94 | PKR 1.95/mL | No comparator |
| Calmether Dry | Artemether + Lumefantrine | 15 mg + 90 mg/5 mL | Dry suspension | 60ml | 075554 | PKR 307.10 | PKR 5.12/mL | 🔒 Pharma Pro |
| Calmether Dry | Artemether + Lumefantrine | 15 mg + 90 mg/5 mL | Dry suspension | 30ml | 075554 | PKR 153.55 | PKR 5.12/mL | 🔒 Pharma Pro |
| Calpem | Meropenem | 500 mg | Injection | 1's | 104132 | PKR 1,882.84 | PKR 1,882.84/vial/unit | 🔒 Pharma Pro |
| Calpem | Meropenem | 1 g | IV injection | 1's | 104133 | PKR 3,519.32 | PKR 3,519.32/vial/unit | 🔒 Pharma Pro |
| Calphacin | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 075555 | PKR 392.41 | PKR 6.54/mL | 🔒 Pharma Pro |
| Calphacin | Clarithromycin | 125 mg/5 mL | Suspension | 30ml | 075555 | PKR 197.08 | PKR 6.57/mL | 🔒 Pharma Pro |
| Calphacin | Clarithromycin | 250 mg | Tablet | 1x10's | 087430 | PKR 422.31 | PKR 42.23/tablet | 🔒 Pharma Pro |
| Calphacin | Clarithromycin | 500 mg | Tablet | 1x10's | 087431 | PKR 703.86 | PKR 70.39/tablet | 🔒 Pharma Pro |
| Calphacin | Clarithromycin | 250 mg/5 mL | Dry suspension | 70ml | 091284 | PKR 665.68 | PKR 9.51/mL | 🔒 Pharma Pro |
| Calphacin | Clarithromycin | 250 mg/5 mL | Dry suspension | 60ml | 091284 | PKR 647.56 | PKR 10.79/mL | 🔒 Pharma Pro |
| Calphacin ER | Clarithromycin | 500 mg | Tablet | 1x5's | 087429 | PKR 364.25 | PKR 72.85/tablet | 🔒 Pharma Pro |
| Calplex | Polysaccharide iron complex | 100 mg | Oral solution | 120ml | 087003 | PKR 213.26 | PKR 1.78/mL | No comparator |
| Calplex | Polysaccharide iron complex | 100 mg | Oral solution | 60ml | 087003 | PKR 136.49 | PKR 2.27/mL | No comparator |
| Calsic | Omeprazole | 20 mg | Capsule | 2x7's | 075563 | PKR 211.16 | PKR 15.08/capsule | 🔒 Pharma Pro |
| Calsic | Omeprazole | 20 mg | Capsule | 10x10's | 075563 | PKR 1,388.37 | PKR 13.88/capsule | 🔒 Pharma Pro |
| Calsic | Omeprazole | 20 mg | Capsule | 1x10's | 075563 | PKR 151.33 | PKR 15.13/capsule | 🔒 Pharma Pro |
| Calsic | Omeprazole | 40 mg | Capsule | 2x7's | 080404 | PKR 439.92 | PKR 31.42/capsule | 🔒 Pharma Pro |
| Calsic | Omeprazole | 40 mg | Capsule | 10x10's | 080404 | PKR 2,543.52 | PKR 25.44/capsule | 🔒 Pharma Pro |
| Calsic | Omeprazole | 40 mg | IV injection | 1'S | 082562 | PKR 527.90 | PKR 527.90/vial/unit | 🔒 Pharma Pro |
| Calworm | Albendazole | 200 mg | Tablet | 1x2's | 074504 | PKR 17.59 | PKR 8.80/tablet | 🔒 Pharma Pro |
| Cepmol | Paracetamol | 250 mg/5 mL | Suspension | 90ml | 073397 | PKR 135.74 | PKR 1.51/mL | 🔒 Pharma Pro |
| Cepmol | Paracetamol | 250 mg/5 mL | Suspension | 60ml | 073397 | PKR 90.50 | PKR 1.51/mL | 🔒 Pharma Pro |
All 51 Caliph Pharmaceuticals brands in Pakistan
- A-zatro Azithromycin · 200 mg/5 mL suspension
- Betacline Betamethasone · 0.05 % lotion, 0.05% ointment
- Betacline V Betamethasone, Betamethasone valerate · 0.1 % lotion, 0.1% lotion
- Betacline-G Betamethasone + Gentamicin · 0.5 mg + 1 mg ointment, 0.5 mg + 1 mg cream, 0.5 mg/g + 1 mg/g ointment
- Betacline-S Betamethasone + Salicylic acid · 0.05% + 2% lotion, 0.5 mg + 20 mg lotion, 0.5 mg + 30 mg ointment
- Bicalutacal Bicalutamide · 150 mg tablet, 50 mg tablet
- Caladar Sulfadoxine + Pyrimethamine · 500 mg + 25 mg suspension
- Calazi Azithromycin · 1 g sachet, 250 mg capsule, 500 mg tablet
- Califer Iron polymaltose complex, Iron · 100 mg elemental iron tablet, 50 mg syrup, 50 mg/5 mL syrup
- Califer-F Iron polymaltose complex + Folic acid, Elemental iron + Folic acid · 50 mg + 0.35 mg/5 mL syrup
- Calmether Dry Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- Calpem Meropenem · 1 g injection, 500 mg injection
- Calphacin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Calphacin ER Clarithromycin · 500 mg tablet
- Calplex Polysaccharide iron complex · 100 mg solution
- Calsic Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Calworm Albendazole · 200 mg tablet
- Cepmol Paracetamol · 120 mg suspension, 120 mg/5 mL suspension, 250 mg/5 mL suspension
- Cipak Ciprofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Cipcal Ciprofloxacin · 125 mg/5 mL suspension
- Cipcal Fort Ciprofloxacin · 250 mg/5 mL suspension
- Clindacal Clindamycin · 1% lotion
- Clindacal Viginal Clindamycin · 2% cream
- Coropulp Hydroxychloroquine · 200 mg tablet
- D-Rick Cholecalciferol · 5 mg (200,000 IU) injection
- D-Tron Ondansetron · 4 mg/5 mL syrup, 8 mg tablet, 8 mg/4 mL injection
- Eixophate Elemental Zinc · 20 mg syrup
- Enzid Linezolid · 100 mg suspension, 100 mg/5 mL suspension, 600 mg tablet
- Flucal Dry Fluconazole · 50 mg/5 mL suspension
- Grancef Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- Hydrocortisone Hydrocortisone · 1 % cream, 1% cream
- Hydrocortisone Acetate Hydrocortisone · 1 % cream
- Keklofz Fluconazole · 150 mg capsule
- Levocal Levofloxacin · 250 mg tablet, 500 mg tablet
- Medopril Loperamide HCl · 2 mg capsule
- Metronidazole Metronidazole · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- Mucocal Acetylcysteine · 200 mg sachet
- Nixcal Permethrin · 5 % lotion, 5% cream
- Orphical Paracetamol + Orphenadrine · 450 mg + 35 mg tablet
- Ozifex 6 Olanzapine + Fluoxetine · 6 mg + 25 mg capsule
- Ramafen Ibuprofen · 100 mg/5 mL suspension
- Ramafen DS Liquid Ibuprofen · 200 mg/5 mL suspension
- Ramafen Liquid Ibuprofen · 100 mg/5 mL suspension
- Ramoxcin Moxifloxacin · 400 mg tablet, 400 mg infusion
- Riscalm Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Roclete-H Miconazole + Hydrocortisone · 2% + 1% w/w cream
- Rovical Voriconazole · 200 mg/5 mL suspension
- Stical Nystatin · 100,000 units/mL drops
- Tamoxical Tamoxifen · 10 mg tablet, 20 mg tablet
- Tenofocal Tenofovir disoproxil · 245 mg tablet
- Unixone Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
Caliph Pharmaceuticals: common questions
How many products does Caliph Pharmaceuticals have in Pakistan?
Caliph Pharmaceuticals (Pvt) Ltd has 116 registered medicine presentations in Pakistan, sold under 51 brands and covering 44 generic medicines.
What are the main brands of Caliph Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Calphacin (Clarithromycin), Calsic (Omeprazole), Riscalm (Risperidone), Betacline-G (Betamethasone + Gentamicin) and Betacline-S (Betamethasone + Salicylic acid). This is not a sales ranking.
Which therapy areas does Caliph Pharmaceuticals cover?
The most products are in Anti-infectives (64), Dermatology (12), Gastrointestinal & hepatology (11), Vitamins, minerals & nutrition (9) and Pain & musculoskeletal (8).
Where can I see Caliph Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.